Healthcare Stocks

A flick through Australia’s oral health plan and dental stocks from ASX

 A flick through Australia’s oral health plan and dental stocks from ASX

SDI Limited and Pacific Smiles Group are two of the dental care stocks from ASX.

Read More...
How are CSL shares performing after finalisation of Vifor acquisition?

How are CSL shares performing after finalisation of Vifor acquisition?

Shares of CSL Limited (ASX:CSL) gained almost 1% on the ASX today although no price sensitive news came from the company’s camp today.

Read More...
Here’s why Mesoblast (ASX:MSB) has suspended trading today

Here’s why Mesoblast (ASX:MSB) has suspended trading today

  • August 08, 2022 03:59 PM AEST | Ritwika

Mesoblast shares went under a voluntary suspension on the ASX today. Trading is expected to commence after the company releases its capital raising announcement on 10 August 2022.

Read More...
CSL, COH, PNV: Take a look at R&D activities of ASX healthcare giants

CSL, COH, PNV: Take a look at R&D activities of ASX healthcare giants

CSL, COH, TLX, NAN, and PNV are some of the major ASX-listed healthcare firms with strong investment and robust R&D activities.

Read More...
Why are Mesoblast (ASX:MSB) shares in trading halt today?

Why are Mesoblast (ASX:MSB) shares in trading halt today?

  • August 04, 2022 12:27 PM AEST | Ashish

Mesoblast Ltd (ASX:MSB) on Thursday said that it would be placing its shares in a trading halt

Read More...
Up 14% in six months, can CSL shares maintain momentum on ASX?

Up 14% in six months, can CSL shares maintain momentum on ASX?

Shares of CSL are in red today (4 August) following the benchmark performance.

Read More...
A glimpse into National Disability Insurance Scheme (NDIS)

A glimpse into National Disability Insurance Scheme (NDIS)

NDIS provides monetary support and assistance to Australians born with or have acquired a permanent and significant disability.

Read More...
Monkeypox cases rising in Australia; Will healthcare giants be impacted?

Monkeypox cases rising in Australia; Will healthcare giants be impacted?

  • July 28, 2022 05:13 PM AEST | Ritwika

Monkeypox is spreading across the entire world. Australia reported 44 confirmed case till now. The government has declared the situation as a 'national significance' . Lets see how it will impact the ASX healthcare sector.

Read More...
CSL Limited (ASX:CSL) gains over 16% in six months, here’s why

CSL Limited (ASX:CSL) gains over 16% in six months, here’s why

  • July 25, 2022 06:43 PM AEST | Ritwika

CSL shares closed in red today probably due to the delay in Vifor acquisition.

Read More...
Nanosonics (ASX:NAN) expects FY22 revenue to touch AU$120M

Nanosonics (ASX:NAN) expects FY22 revenue to touch AU$120M

Shares of Nanosonics (ASX:NAN) dropped by over 9% today despite sharing that its shipping volume has increased considerably

Read More...
Why CSL Limited (ASX:CSL) shares closed strong on Thursday?

Why CSL Limited (ASX:CSL) shares closed strong on Thursday?

  • July 21, 2022 06:20 PM AEST | Ritwika

CSL shares have closed in green today probably due to the sectoral influence. The S&P/ASX 200 Health Care sector was one of the best performing sectors on the ASX today.

Read More...

Frequently Asked Questions

Given the fact that healthcare is a necessity, investing in healthcare stocks can be rewarding. However, to make good returns from these stocks, an investor should have sound knowledge about the sector and should be aware of the latest trends in the sector.

The standard checklist that one would run to find a good stock, holds true for screening healthcare stocks too. However, there are few aspects that are important to be considered for healthcare stocks. Well established pharmaceutical stocks with a good history of drug discovery and effective treatments typically have some sort of moat around them, thanks to their scale and financial wherewithal. However, new, and small companies with unique innovations or a strong product pipeline are also worth investigating, as they have a longer runway. Healthcare companies are able to pass on inflation-led input cost pressure, since people usually do not cut back on their healthcare expenses even during an inflationary environment. Companies that are able to maintain good profit margin are seen commanding valuation premiums in the market. Investors can also look for healthcare companies with strong patent portfolio, as patents can provide good price and competition protection for longer periods. Finally, before finalising any share, some of the fundamentals such as return on equity, revenue growth, net margin growth, management capabilities in terms of capital allocation, dividend pay-out should be considered.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK